Production and processing of a recombinant Fasciola hepatica cathepsin B-like enzyme (FhcatB1) reveals potential processing mechanisms in the parasite

被引:33
作者
Beckham, Simone A.
Law, Ruby H. -P.
Smooker, Peter M.
Quinsey, Noelene S.
Caffrey, Conor R.
McKerrow, James H.
Pike, Robert N. [1 ]
Spithill, Terry W.
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
[2] RMIT Univ, Sch Appl Sci, Bundoora, Vic 3083, Australia
[3] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA
[4] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada
[5] McGill Univ, Ctr Host Parasite Interact, Ste Anne De Bellevue, PQ H9X 3V9, Canada
关键词
cathepsin B; Fasciola hepatica; liver fluke; processing;
D O I
10.1515/BC.2006.130
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The liver fluke, Fasciola hepatica, apparently uses a number of cysteine proteases during its life cycle, most likely for feeding, immune evasion and invasion of tissues. A cathepsin B-like enzyme (herein referred to as FhcatB1) appears to be a major enzyme secreted by the invasive, newly excysted juvenile flukes of this parasite. To examine the processing mechanisms for this enzyme, a recombinant form was expressed in Pichia pastoris and purified to yield a homogenous pool of the enzyme. The purified enzyme could be autoactivated at low pH via a bi-molecular mechanism, a process that was greatly accelerated by the presence of large, negatively charged molecules such as dextran sulfate. The enzyme could also apparently be processed to the correct size by an asparaginyl endopeptidase via cleavage in an unusual insertion N-terminal to the normal cleavage site used to yield the active form of the enzyme. Thus, there appear to be a number of ways in which this enzyme can be processed to its optimally active form prior to secretion by F. hepatica.
引用
收藏
页码:1053 / 1061
页数:9
相关论文
共 39 条
  • [21] SURFACE ACTIVATION OF PRO-CATHEPSIN-L
    MASON, RW
    MASSEY, SD
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (03) : 1659 - 1666
  • [22] Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries
    Mathieu, MA
    Bogyo, M
    Caffrey, CR
    Choe, Y
    Lee, J
    Chapman, H
    Sajid, M
    Craik, CS
    McKerrow, JH
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2002, 121 (01) : 99 - 105
  • [23] Molecular cloning and analysis of stage and tissue-specific expression of cathepsin B encoding genes from Fasciola gigantica
    Meemon, K
    Grams, R
    Vichasri-Grams, S
    Hofmann, A
    Korge, G
    Viyanant, V
    Upatham, ES
    Habe, S
    Sobhon, P
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2004, 136 (01) : 1 - 10
  • [24] Metcalfe D D, 1979, Monogr Allergy, V14, P236
  • [25] Folding competence of N-terminally truncated forms of human procathepsin B
    Müntener, K
    Willimann, A
    Zwicky, R
    Svoboda, B
    Mach, L
    Baici, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) : 11973 - 11980
  • [26] THE REFINED 2.15-A X-RAY CRYSTAL-STRUCTURE OF HUMAN LIVER CATHEPSIN-B - THE STRUCTURAL BASIS FOR ITS SPECIFICITY
    MUSIL, D
    ZUCIC, D
    TURK, D
    ENGH, RA
    MAYR, I
    HUBER, R
    POPOVIC, T
    TURK, V
    TOWATARI, T
    KATUNUMA, N
    BODE, W
    [J]. EMBO JOURNAL, 1991, 10 (09) : 2321 - 2330
  • [27] Potter K, 2001, ARTHRITIS RHEUM, V44, P846, DOI 10.1002/1529-0131(200104)44:4<846::AID-ANR141>3.0.CO
  • [28] 2-E
  • [29] The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide
    Quraishi, O
    Nägler, DK
    Fox, T
    Sivaraman, J
    Cygler, M
    Mort, JS
    Storer, AC
    [J]. BIOCHEMISTRY, 1999, 38 (16) : 5017 - 5023
  • [30] The propeptide of Fasciola hepatica cathepsin L is a potent and selective inhibitor of the mature enzyme
    Roche, L
    Tort, J
    Dalton, JP
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1999, 98 (02) : 271 - 277